meglumine antimoniate has been researched along with thalidomide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdi, K; Darabi, M; Ghareghozloo, B; Kariminia, A; Solgi, G | 1 |
| Goyonlo, VM; Taghavi, F; Vahabi-Amlashi, S | 1 |
2 other study(ies) available for meglumine antimoniate and thalidomide
| Article | Year |
|---|---|
Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice.
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Female; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Interleukin-12; Leishmania major; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Thalidomide; Time Factors | 2006 |
Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis.
Topics: Antiprotozoal Agents; Humans; Iran; Leishmania tropica; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Nose; Thalidomide; Young Adult | 2019 |